Live Breaking News & Updates on Eptember 9 Ani Businesswire India Terumo

New Delhi [India], September 9 (ANI/BusinessWire India): Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced the launch of FineGlide, Sterile Pen Needle for patients requiring regular insulin injections or other self-medication. Designed to be compatible with most commonly available pen devices in India, Fineglide raises the bar for patient comfort and thereby, drug compliance. Making the announcement, Managing Director of Terumo India, Shishir Agarwal said, "Patient comfort and convenience are critical attributes that have significant impact on their adherence to therapy. We are delighted to introduce FineGlide to patients and healthcare providers in India as it raises the bar for patient comfort." It is estimated that close to 78 million patients in India are having Diabetes, of these about 12 per cent patients require insulin daily to manage the disease and also there are other therapies wherein self-inject ....

New Delhi , Shishir Agarwal , Ashit Sikka , Wall Technology , Terumo Medical Care Solutions , Terumo Corporation , Life Care Solutions , Businesswire India , Terumo India , Sterile Pen Needle , Managing Director , Senior Director , Thin Wall Technology , New Delhi India , Eptember 9 Ani Businesswire India Terumo , He Indian Arm Of Terumo Corporation Tse 4543 , A Global Leader In Medical Technology , Oday Announced The Launch Of Fineglide , Terile Pen Needle For Patients Requiring Regular Insulin Injections Or Other Self Medication Designed To Be Compatible With Most Commonly Available Devices In India , Ineglide Raises The Bar For Patient Comfort And Thereby , Rug Compliance Making The Announcement , Anaging Director Of Terumo India , Hishir Agarwal Said , Uot Patient Comfort And Convenience Are Critical Attributes That Have Significant Impact On Their Adherence To Therapy We Delighted Introduce Fineglide Patients Healthcare Providers In India As It Raises The Bar For Quot Is Estimated Close 78 Million Having Diabetes , F These About 12 Per Cent Patients Require Insulin Daily To Manage The Disease And Also There Are Other Therapies Wherein Self Injection Pen Devices Needles Which Used For Drug Delivery Elaborating On Need Further , Ashit Sikka ,